Adipose-derived stem cell wrapped hydrogel-acellular matrix bladder patch and preparation method and application thereof

Through the hydrogel-decellularized matrix bladder patch that wraps fat stem cells, the problems of limited seed cell differentiation and lack of vascularization of scaffold materials are solved, and bladder patches suitable for bladder repair are constructed, achieving effective repair of large-scale bladder defects and physiological function protection.

CN119015508AInactive Publication Date: 2024-11-26THE THIRD MEDICAL CENT OF THE CHINESE PEOPLES LIBERATION ARMY GENERAL HOSPITAL

Patent Information

Application Number
CN202411144034.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-20
Publication Date
2024-11-26
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the existing bladder tissue engineering technology, seed cells have limited complete differentiation, scaffold materials lack vascularization and neurification, and repair materials are difficult to cope with the complex situations caused by urine soaking, peritoneal friction and bladder contraction and diastolicity.

Method used

Using hydrogel-decellular matrix bladder patches that wrap fatty stem cells, using ultraviolet cross-linking by reacting type A gelatin with methacrylic anhydride and mixing with phosphate buffer and photoinitiator. Build bladder patches to provide a semi-protected growth environment.

Benefits of technology

A bladder patch with good mechanical properties and suturability is constructed, which can effectively repair large-scale bladder defects in the body, protect physiological functions, and has great clinical application potential.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119015508A_ABST
    Figure CN119015508A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of biological materials, and particularly relates to a hydrogel-acellular matrix bladder patch wrapping adipose-derived stem cells as well as a preparation method and application of the hydrogel-acellular matrix bladder patch. The preparation method comprises the following steps: firstly, preparing methacrylated gelatin and a bladder acellular matrix, then mixing the methacrylated gelatin with adipose-derived stem cells, and carrying out photocuring on the obtained mixture on the muscle surface of the bladder acellular matrix to finally obtain the BAM-GelMA-ADSC patch. Strict experimental characterization is carried out in the preparation process, a beagle bladder reconstruction operation is finally carried out, and imaging, functional and histological examinations prove that the BAM-GelMA patch loaded with the ADSC has a good repairing effect in vivo, is suitable for repairing large-scale defects of the bladder, can effectively protect the physiological function of the bladder, and has a good application prospect. The great clinical transformation and application potential is realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biomaterials, and in particular relates to a hydrogel-acellular matrix bladder patch encapsulating adipose stem cells, and a preparation method and application thereof. Background Art

[0002] Congenital and acquired bladder diseases, such as bladder tumors, bladder injuries, bladder exstrophy, and neurogenic bladder, may lead to anatomical or functional defects of the bladder. Taking the most common bladder tumor of the urogenital system as an example, the World Health Organization statistics in 2020 show that there are 573,000 new cases of bladder cancer each year in the world, and about 85,700 new cases of bladder cancer each year in China, and there is a huge gap in the medical demand for bladder reconstruction. At present, the use of the body's own intestines for repair and reconstruction after cystectomy is the gold standard for bladder reconstruction treatment. However, due to the huge differences in tissue structure and function between the intestine and the bladder, the use of intestines to repair and reconstruct bladder tissue is often accompanied by a series of complications: such as poor contraction, recurrent infection, stone formation, metabolic disorders, and malignant transformation. Therefore, it is urgent to explore a new method of bladder repair and reconstruction in clinical work, from partial bladder repair to full bladder replacement reconstruction, to achieve the reconstruction and restoration of bladder structure and function with a focus on coordinated physiological urination function, and improve the quality of life of patients. In recent years, with the innovation and development of tissue engineering technology, the construction of engineered bladder tissue in vitro to repair or replace damaged bladders has provided a new treatment strategy for bladder reconstruction and has broad clinical application prospects.

[0003] At present, the existing technology of bladder tissue engineering mainly uses seed cells, biomaterials and growth factors to construct bladder patches or bladder scaffolds. Seed cells are the basis of bladder tissue engineering research. Previously, researchers have used mesenchymal stem cells, bladder smooth muscle cells, and urothelial cells to construct tissue engineering patches. For example, Gu co-cultured smooth muscle cells with endothelial progenitor cells to form a pre-vascularized smooth muscle cell membrane to repair bladder muscle wall defects. However, this terminally differentiated cell is a cell of autologous origin, which is completely differentiated and has limited in vitro expansion ability, so its application in tissue engineering bladder construction is limited.

[0004] On the other hand, the scaffold material is the basis for the adhesion and growth of seed cells. The selection of scaffold materials is particularly important in bladder tissue engineering research. Most of the current studies only inoculate cells on bare BAM scaffolds. The cells lack an environment for growth, and the risk of shedding and death is high. In addition, they are lacking in vascularization and neuralization, and new construction methods need to be introduced. Cell delivery is one of the important treatment methods in regenerative medicine and tissue engineering. Hydrogels are a class of biopolymers derived from natural or synthetic products. They have high water content and properties similar to the extracellular matrix. They also have good biocompatibility and degradability and can be used as cell carriers for tissue repair. However, the bladder is a relatively complex application scenario. The repair material needs to face the immersion of urine, the friction of the peritoneum, and the stretching and deformation caused by the contraction and relaxation of the bladder. At present, there are almost no hydrogels that can cope with these complex situations alone.

[0005] Therefore, based on this, the technical solution of the present invention is proposed. Summary of the invention

[0006] In order to solve the problems existing in the prior art, the present invention provides a method for preparing a hydrogel-acellular matrix bladder patch encapsulating adipose stem cells, and the preparation method comprises the following steps:

[0007] (1) mixing type A gelatin with water, heating and stirring, to obtain a gelatin solution;

[0008] (2) adding methacrylic anhydride to the gelatin solution to react and obtain a reaction solution;

[0009] (3) dialyzing and freeze-drying the reaction solution in sequence to obtain methacryloyl gelatin;

[0010] (4) mixing the methacrylated gelatin with a phosphate buffer solution and a photoinitiator solution to obtain a photoreaction premix solution;

[0011] (5) mixing the intact animal bladder mucosal layer tissue with a surfactant solution, shaking it, and then washing it to remove the residual decellularization solution to obtain a bladder decellularized matrix;

[0012] (6) The adipose-derived stem cells are combined with the photoreaction premix and evenly dripped onto the muscle layer of the bladder decellularized matrix, and then a photoinduced reaction is performed to obtain the hydrogel-decellularized matrix bladder patch encapsulating the adipose-derived stem cells.

[0013] Preferably, in step (1), the mass and volume ratio of type A gelatin to water is 1:10-11.

[0014] Preferably, in step (1), the heating temperature is 50-60°C.

[0015] Preferably, in step (2), the reaction conditions are: reacting at 50-55° C. for 3-4 hours in a light-proof condition.

[0016] Preferably, in step (3), the dialysis temperature is 50-55° C., the dialysis time is 7-9 days, and the freeze-drying time is 2-3 days.

[0017] Preferably, in step (4), the concentration of methacryloyl gelatin in the photoreaction premix is ​​7.5 to 12.5 wt.%.

[0018] Preferably, in step (6), the conditions for the photoinitiated reaction are: irradiation under 405 nm ultraviolet light for 40 s, with a light intensity of 80 mW / cm 2 .

[0019] Based on the same technical concept, the present invention also provides a hydrogel-acellular matrix bladder patch encapsulating adipose stem cells obtained by the preparation method.

[0020] Based on the same technical concept, the present invention also provides an application of a hydrogel-acellular matrix bladder patch encapsulating adipose stem cells in the preparation of bladder repair materials.

[0021] The beneficial effects of the present invention are:

[0022] The present invention firstly carried out mechanical detection, swelling detection, degradation performance detection and biocompatibility detection on GelMA of different concentrations, characterized GelMA in detail, clarified the optimal concentration of encapsulating ADSC, and provided a semi-protected space environment for stem cells. Secondly, the prepared BAM was biologically and mechanically characterized, and evaluated from the perspective of clinical use and suturing, proving that the prepared BAM has good mechanical properties and sutureability, and is suitable for clinical operation. Again, GelMA was mixed with ADSC, then dripped on the muscle layer of BAM, and 405nm ultraviolet light was used for rapid photocrosslinking to construct a BAM-GelMA-ADSC tissue engineering bladder patch. Finally, bladder reconstruction surgery was performed on beagles, and imaging, functional and histological examinations were performed to prove that the BAM-GelMA patch loaded with ADSC has a good repair effect in vivo, is suitable for repairing large-scale defects in the bladder, can effectively protect the physiological function of the bladder, and has great clinical transformation and application potential. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0024] Figure 1 This is a photo of the appearance of GelMA.

[0025] Figure 2 This is an electron micrograph of the pore structure of 7.5% GelMA.

[0026] Figure 3 This is an electron micrograph of the pore structure of 10% GelMA.

[0027] Figure 4 This is an electron micrograph of the pore structure of 12.5% ​​GelMA.

[0028] Figure 5 This is a comparison of the porosity of three concentrations of GelMA (**P<0.01, ****P<0.0001).

[0029] Figure 6 This is the swelling and degradation performance diagram of GelMA (***P<0.001, ****P<0.0001).

[0030] Figure 7 is the mechanical properties diagram of GelMA (****P<0.0001).

[0031] Figure 8 This is a histological comparison of BAM and native bladder.

[0032] Fig. 9 This is the mechanical properties test result of BAM (ns: no statistically significant difference).

[0033] Fig.10 The maximum tensile force data of suture on BAM and the maximum tensile force data of suture (ns: no statistically significant difference).

[0034] Fig.11 This is a graph showing the biocompatibility test results of GelMA.

[0035] Fig.12 This is a diagram of BAM's biocompatibility test results.

[0036] Fig.13 These are electron microscope images of BAM-GelMA-ADSC and images of the bladder defect repaired and the effect after repair.

[0037] Fig.14 This is a diagram evaluating the repair effect of the tissue engineering bladder patch 12 weeks after surgery. DETAILED DESCRIPTION

[0038] To make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described in detail below. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other implementation methods obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention.

[0039] Example 1

[0040] The present invention provides a method for preparing a hydrogel-acellular matrix bladder patch encapsulating adipose stem cells, the preparation method comprising the following steps:

[0041] (1) Weighing 10 g of type A gelatin from pig skin using a balance, adding it to 100 mL of deionized water, and heating it to 50° C. to obtain a gelatin solution with a concentration of 10% (w / v);

[0042] (2) maintaining the temperature unchanged, slowly dropping 1 mL of methacrylic anhydride into the gelatin solution under stirring (the dropping time is controlled within 30 min), and then reacting at 50° C. for 3 h in a light-proof condition to obtain a reaction solution;

[0043] (3) The reaction solution was poured into a dialysis bag (MD44, 8000-14000D), and dialyzed with deionized water at 50°C for 7 days (the water was changed 3 times a day), and then frozen in a -80°C ultra-low temperature refrigerator overnight, and then freeze-dried in a freeze dryer for 2 days to obtain a dry white foam sample, which is methacryloyl gelatin (GelMA); the appearance photo of GelMA is shown in FIG. Figure 1 As shown;

[0044] (4) Dissolve 1 g of GelMA in 9 mL of phosphate buffer saline (PBS), wrap it with tin foil to avoid light, and heat it in a 60°C water bath to dissolve. During the process, shake and mix it. After GelMA is completely dissolved, add 1 mL of 2.5% photoinitiator (Lithium phenyl-2,4,6-trimethylbenzoylphosphinate, LAP) to obtain a 10% (w / v) photoreaction premix (i.e., GelMA hydrogel), in which the final concentration of LAP is 0.25 (v / v)%.

[0045] (5) After the fresh pig bladder (purchased from the market) was cleaned, the bladder mucosa layer was completely separated using scissors, and the complete mucosa tissue was placed in a plastic box, 500 mL of 1% TritonX-100 solution was added, and the mixture was shaken on a shaker (80 r / min) for 8 h, and then washed with deionized water for 20 min to wash away the residual 1% TritonX-100 solution; 500 mL of 1% SDS solution was added, and the mixture was shaken on a shaker (80 r / min) for 8 h, and finally washed with deionized water for 20 min to wash away the residual decellularized solution, thereby obtaining a bladder acellular matrix (BAM);

[0046] (6) Take the third generation of adipose-derived stem cells (ADSCs) and count 1×10 7 1 mL of GelMA hydrogel was then added and mixed, and then evenly dropped onto the myometrium of the BAM and irradiated with 405 nm UV light for 40 s at an intensity of 80 mW / cm 2 , a hydrogel-acellular matrix bladder patch encapsulating adipose stem cells (BAM-GelMA-ADSC patch) was constructed.

[0047] Example 2

[0048] This embodiment provides a method for preparing a hydrogel-acellular matrix bladder patch encapsulating adipose stem cells. The difference from Example 1 is that in step (4), a 7.5% (w / v) photoreaction premix (i.e., GelMA hydrogel) is obtained in this embodiment, and the remaining operations are the same as those in Example 1.

[0049] Example 3

[0050] This embodiment provides a method for preparing a hydrogel-acellular matrix bladder patch encapsulating adipose stem cells. The difference from Example 1 is that in step (4), a 12.5% ​​(w / v) photoreaction premix (i.e., GelMA hydrogel) is obtained, and the remaining operations are the same as those in Example 1.

[0051] Effect verification example

[0052] (I) Synthesis and characterization of GelMA

[0053] (1) Synthesis of GelMA

[0054] The synthesis was carried out according to the method described in the embodiment of the present invention, specifically: 10g of type A gelatin from pig skin was weighed on a balance and added to 100mL of deionized water to prepare a 10% (w / v) solution. Heat and stir at 50°C, then slowly add 1mL of methacrylic anhydride to the gelatin solution (the dropping time was controlled within 30min). Then react for 3h at 50°C under light-proof conditions. The reacted mixed solution was poured into a dialysis bag (MD44, 8000-14000D) and dialyzed with deionized water at 50°C for about 7 days (changing water 3 times a day). After that, it was frozen overnight in a -80°C ultra-low temperature refrigerator, and then freeze-dried for 2 days using a freeze dryer to obtain a dry white foam sample, which is GelMA.

[0055] (2) GelMA hydrogel concentration grouping

[0056] Weigh 0.75g, 1g and 1.25g of freeze-dried GelMA, respectively, dissolve each in 9mL of PBS buffer, wrap with tin foil to avoid light, heat in a 60℃ water bath to dissolve, and shake to mix. After GelMA is completely dissolved, add 1mL of 2.5% photoinitiator LAP. Thus, 7.5%, 10%, and 12.5% ​​(w / v) GelMA hydrogels are obtained, respectively, with a final concentration of LAP of 0.25 (v / v)%.

[0057] (3) Scanning electron microscopy characterization of GelMA hydrogel

[0058] Each group of hydrogels was cross-linked (cross-linking conditions were photoinitiated: irradiated under 405 nm ultraviolet light for 40 s, light intensity was 80 mW / cm 2 , the same below) cylinder was then freeze-dried, and the freeze-dried sample was taken out and placed in liquid nitrogen to obtain a cross section. After the sample was sprayed with gold, its morphology and pores were observed by scanning electron microscopy. The results were as follows Figure 2 to Figure 4 .

[0059] Depend on Figure 2 to Figure 4 It can be seen that all three groups of GelMA hydrogels have interconnected and evenly distributed pores, which enables cells to attach to the inside of the hydrogel and exchange substances with the external environment. Furthermore, Figure 5 As shown in the figure, the porosity of 7.5% GelMA, 10% GelMA and 12.5% ​​GelMA are 75.58±1.17%, 65.07±2.19% and 42.73±3.34% respectively. The results show that the higher the concentration of GelMA, the denser the internal structure, the smaller the pores, and the more unfavorable it is for nutrient exchange.

[0060] (4) Swelling rate and degradation rate detection

[0061] Each group of hydrogels was cross-linked into cylinders and then freeze-dried, and the dry weight (Wd) was weighed. The samples were then immersed in PBS buffer, and the hydrogel samples were taken out at 3h, 6h, 12h, 24h and 48h. The water on the surface of the samples was gently wiped with absorbent paper and weighed (Wt). The swelling rate was calculated as follows: Swelling rate (%) = (Wt-Wd) / Wd×100%

[0062] The results of the swelling experiment are as follows Figure 6 A and Figure 6 As shown in Figure B, the results show that 12.5% ​​GelMA reaches swelling equilibrium at 48h, with a swelling rate of 789.79±56.00%, while the swelling rates of 7.5% GelMA and 10% GelMA are 1170.84±51.97% and 908.71±45.00%, respectively, and there is an upward trend. The reason may be that the loose network structure and high porosity of low-concentration hydrogel make it easier to absorb water and swell, providing a wider space for cell diffusion, which will be beneficial to cell growth and wound healing.

[0063] Subsequently, each group of hydrogels was cross-linked into cylinders and then freeze-dried, and the dry weight (W0) was weighed. The samples were then soaked in PBS buffer for 2 days, then transferred to EP tubes, and 1 mL of PBS containing 2 U / mL of type II collagenase was added. At different time points (2h, 4h, 6h, 8h), the liquid was aspirated and the remaining hydrogel samples were freeze-dried, and their freeze-dried weight (W1) was weighed. The calculation formula for the degradation rate is as follows: Degradation rate (%) = (W0-W1) / W0×100%.

[0064] The degradation rate is an important consideration after the patch is implanted in the body, because sufficient cell proliferation and survival must be ensured before the hydrogel is completely degraded to achieve the best repair and regeneration effect. Figure 6 C and Figure 6 As shown in D, the results show that 7.5% GelMA degraded the fastest and was almost completely degraded at 8h (99.62±0.43%). After transplantation into the body, it may not provide a long-term growth site for cell proliferation. The degradation rates of the other two groups at 8h were 79.51±2.04% and 63.74±2.70%, and some hydrogels still remained, indicating that the degradation rates of 10% GelMA and 12.5% ​​GelMA are relatively more adapted to the in vivo environment.

[0065] (5) Mechanical properties testing

[0066] Each group of hydrogels was cross-linked to form a cylinder (5 mm in height and 10 mm in diameter). The samples were placed on a universal mechanical testing machine for compression testing at a compression strain rate of 1 mm / min. The mechanical properties test results are shown in Figure 7 As shown. Figure 7 It can be seen that the maximum compressive strain is 70%, and the Young's modulus is calculated based on the stress-strain data.

[0067] The Young's modulus of the three groups of hydrogels were 180.78±15.0kPa (7.5% GelMA), 492.30±50.14kPa (10% GelMA), and 704.04±29.35kPa (12.5% ​​GelMA), and they all maintained their morphology intact at 70% strain, with good deformability. Under the same deformation conditions, the Young's modulus of high-concentration GelMA is higher, and the compressive stress is also greater. The higher mechanical properties are more conducive to surgical operation and implantation.

[0068] (II) Preparation and characterization of BAM

[0069] (1) Preparation of BAM

[0070] After cleaning the fresh pig bladder (purchased from the market), use scissors to completely separate its bladder mucosal layer. Put the complete mucosal layer tissue into a plastic box, add 500mL of 1% TritonX-100 solution and shake it on a shaker (80r / min) for 8h. Then wash with deionized water for 20min to wash away the residual 1% TritonX-100 solution. Add 500mL of 1% SDS solution and shake it on a shaker (80r / min) for 8h. Finally, wash with deionized water for 20min to wash away the residual decellularized solution to obtain the bladder decellularized matrix.

[0071] (2) BAM staining characterization

[0072] After treatment, BAM changed from pink to white, and the cell components were removed. HE and Masson staining showed that compared with the bladder mucosa, BAM removed a large number of cell components and retained a loose collagen mesh skeleton structure, which was conducive to the inoculation, adhesion and growth of cells (such as Figure 8 shown).

[0073] (3) BAM tensile test

[0074] The bladder mucosa and BAM were cut into strips with a length of 3 cm, a width of 1.5 cm, and a thickness of 1 mm. They were placed on a universal mechanical testing machine for tensile testing. The gap between the clamps was set to 20 mm, the test speed was fixed at 50 mm / min, and the stretching was performed until it broke. The tensile stress, fracture strain, and Young's strain were calculated based on the stress-strain data. The results are shown in Figure 2. Fig. 9 As shown by Fig. 9It can be seen that BAM has excellent mechanical properties. Its maximum tensile strain (256.76±44.71%), maximum tensile stress (221.86±19.31kPa) and Young's modulus (88.10±14.54kPa) are close to those of natural bladder (278.06±29.33%), (232.42±10.08kPa) and (84.08±6.58kPa), meeting the mechanical requirements of bladder.

[0075] (4) BAM patch anti-wire cutting test

[0076] Prepare the same sample and use 5-0 absorbable suture to pass through the middle of the sample. One end of the patch is fixed on the universal mechanical testing machine, and the silk thread is fixed under the tensile machine for tensile testing. The gap between the clamps is set to 30mm, the test speed is fixed to 50mm / min, and the sample is stretched until the silk thread cuts through the sample, and the maximum tensile force is calculated. The results are as follows Fig.10 As shown by Fig.10 It can be seen that BAM has excellent cutting resistance when the silk thread is pulled. The maximum tensile forces of the bladder and BAM are (2.63±0.37N) and (2.51±0.50N), respectively, and the maximum tensile force that the silk thread itself can withstand is (13.63±0.73N), indicating that BAM has excellent suturing properties.

[0077] (III) Patch biocompatibility testing

[0078] (1) Live-dead staining of ADSCs in GleMA

[0079] The hydrogel was sterilized by filtration using a 0.22 μm filter. ADSCs at generation P3 were collected and counted at 1×10 7 / mL density was mixed with three groups of GleMA hydrogels. 100 μL of hydrogel from each group was evenly dropped onto a glass slide and irradiated with 405 nm UV light for 40 s (light intensity 80 mW / cm 2 ), then the slides were transferred to a 24-well plate and 500 μL of canine adipose-derived mesenchymal cell complete culture medium was added. Live-dead staining was performed after 1, 4, and 7 days of culture.

[0080] (2) Detection of proliferation activity of ADSCs in GleMA

[0081] ADSCs were collected at P3 and 1 × 10 7 The density of 10 μL / mL was mixed with three groups of GleMA hydrogels, and then the hydrogels were inoculated into 96-well plates, with 10 μL per well. Complete culture medium was added after photocrosslinking. After 1, 4, and 7 days of culture, CCK-8 assay was performed to detect the proliferation activity of cells in hydrogels.

[0082] (3) Cytoskeleton staining

[0083] After culturing GelMA-ADSC bio-ink on glass slides for 7 days, the cells were washed twice with PBS and fixed with 4% paraformaldehyde at room temperature. After permeabilization and blocking, the cells were stained for cytoskeleton and actin morphology was observed.

[0084] (4) Biocompatibility of BAM

[0085] After BAM was sterilized by irradiation, it was immersed in the complete medium of canine adipose mesenchymal cells for 48 h, and then the extract was collected. 7 / mL density was mixed with 10% GleMA hydrogel. BAM extract and complete culture medium were used as experimental group and control group respectively, and live-death staining, proliferation activity detection and cytoskeleton staining were performed according to the above methods.

[0086] like Fig.11 As shown, the above test found that on the seventh day, the proportion of live cells in 7.5% GelMA (99.0±1.75%) and 10% GelMA (99.31±0.62%) was higher than that in 12.5% ​​GelMA (83.40±2.12%). CCK-8 results showed that the cell proliferation activity of 12.5% ​​GelMA was significantly lower than that of the other two groups, which was consistent with the results of cell live and dead staining. Moreover, cytoskeleton staining on the 7th day showed that the cells in 7.5% GelMA and 10% GelMA showed good extensibility, and the cell extension length was better than that of the 12.5% ​​GelMA group. Crucially, on the 4th and 7th days, the cell proliferation activity of the 10% GelMA group was significantly higher than that of the 7.5% GelMA group. This shows that the biocompatibility of 10% GleMA hydrogel is the best among the three concentrations. Combined with its mechanical, swelling and degradation properties, 10% GelMA is most suitable for encapsulating ADSCs and constructing tissue engineering bladder patches.

[0087] Then, the effects of BAM extract and normal culture medium on cells were tested in 10% GleMA hydrogel. Fig.12 As shown: There was no difference between the two, which shows that the BAM we prepared also has good biocompatibility.

[0088] (IV) In vivo repair of BAM-GelMA-ADSC tissue-engineered bladder patch

[0089] Take the third generation ADSCs and count 1×10 7 cells, and then 1 mL of GelMA (10%) was added and mixed. The hydrogel was evenly dropped onto the muscle layer of BAM, and a BAM-GelMA-ADSC double-layer patch was constructed after photoinitiated curing. After freeze-drying, the microstructure was observed by scanning electron microscopy (eg Fig.13 A).

[0090] On the other hand, tissue engineering bladder patch was used to repair bladder injury in beagle dogs. 40% of the tissue at the top of the bladder of the beagle dogs was removed and repaired using a BAM-GelMA-ADSC double-layer patch. In actual operation, it was found that the patch had good toughness and suturing properties. After suturing, it could keep urine from leaking. It is an excellent biomaterial patch (such as Fig.13 B and Fig.13 C).

[0091] (V) Evaluation of the repair effect of BAM-GelMA-ADSC tissue engineering bladder patch

[0092] Twelve weeks after surgery, the beagle dogs underwent bladder CT, cystoscopy, and histological examination. Fig.14 As shown in the figure: At 12 weeks, the surface of the bladder repair area of ​​the BAM-GelMA-ADSC patch was covered with omental fat, and the color and morphology were close to normal bladder; CT three-dimensional reconstruction found that the bladder had good morphology, and the patch repair traces were faintly visible in the middle of the bladder, with a smooth surface close to normal tissue; under cystoscopy, it was observed that the repair area was close to the normal bladder mucosa, and the healing tissue surface was flat with rich blood supply. H&E staining 12 weeks after surgery showed that in the middle of the BAM-GelMA-ADSC repair area (the position shown by the dotted line in Figure D), more regenerated smooth muscle bundles (black triangles) were visible, surrounded by collagen fiber tissue, accompanied by a small amount of blood vessel regeneration, and the absorbable sutures were completely degraded. Urothelial cell proliferation and multilayer structure can be observed in the urothelial layer. In general, the BAM-GelMA patch loaded with ADSCs is suitable for repairing large-scale bladder defects and has great potential for clinical application.

[0093] The above is only a specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.

Claims

1. A method for preparing a hydrogel-acellular matrix bladder patch encapsulating adipose stem cells, characterized in that: The preparation method comprises the following steps: (1) mixing type A gelatin with water, heating and stirring, to obtain a gelatin solution; (2) adding methacrylic anhydride to the gelatin solution to react and obtain a reaction solution; (3) dialyzing and freeze-drying the reaction solution in sequence to obtain methacryloyl gelatin; (4) mixing the methacrylated gelatin with a phosphate buffer solution and a photoinitiator solution to obtain a photoreaction premix solution; (5) mixing the intact animal bladder mucosal layer tissue with a surfactant solution, shaking it, and then washing it to remove the residual decellularization solution to obtain a bladder decellularized matrix; (6) The adipose-derived stem cells are combined with the photoreaction premix and evenly dripped onto the muscle layer of the bladder decellularized matrix, and then a photoinduced reaction is performed to obtain the hydrogel-decellularized matrix bladder patch encapsulating the adipose-derived stem cells.

2. The method for preparing the hydrogel-acellular matrix bladder patch encapsulating adipose stem cells according to claim 1, characterized in that: In step (1), the mass and volume ratio of type A gelatin to water is 1:10-11.

3. The method for preparing the hydrogel-acellular matrix bladder patch encapsulating adipose stem cells according to claim 1, characterized in that: In step (1), the heating temperature is 50-60°C.

4. The method for preparing the hydrogel-acellular matrix bladder patch encapsulating adipose stem cells according to claim 1, characterized in that: In step (2), the reaction conditions are: reacting at 50-55° C. for 3-4 hours in a light-proof condition.

5. The method for preparing the hydrogel-acellular matrix bladder patch encapsulating adipose stem cells according to claim 1, characterized in that: In step (3), the dialysis temperature is 50-55° C., the dialysis time is 7-9 days, and the freeze-drying time is 2-3 days.

6. The method for preparing the hydrogel-acellular matrix bladder patch encapsulating adipose stem cells according to claim 1, characterized in that: In step (4), the concentration of methacryloyl gelatin in the photoreaction premix is ​​7.5 to 12.5 wt.%.

7. The method for preparing the hydrogel-acellular matrix bladder patch encapsulating adipose stem cells according to claim 1, characterized in that: In step (6), the conditions for the photoinitiated reaction are: irradiation with 405 nm ultraviolet light for 40 s, with a light intensity of 80 mW / cm 2 .

8. The hydrogel-acellular matrix bladder patch encapsulating adipose stem cells obtained by the preparation method according to any one of claims 1 to 7.

9. Use of the hydrogel-acellular matrix bladder patch encapsulating adipose stem cells as claimed in claim 8 in the preparation of bladder repair materials.

Citation Information

Patent Citations

  • Preparation method and application of acellular matrix biological material

    CN105013014A

  • Bladder acellular matrix-cell-three-dimensional fiber network based bionic tissue and preparation method thereof

    CN106075597A

  • Mesenchymal stem cell scaffold for inducing angiogenesis as well as preparation method and application of mesenchymal stem cell scaffold

    CN114606184A

  • ADSCs conditioned medium, preparation method thereof and methylacryloyl gelatin loaded with ADSCs conditioned medium

    CN116286622A

  • Composition containing mesenchymal stem cells and hydrogel, and use thereof

    WO2023072161A1

Cited By

  • Preparation method of in-situ gelation collagen-based biological patch

    CN119792649A

  • 3D bio-printed vascularization-promoting bladder patch and preparation method thereof

    CN119971139A